secwatch.observer — SEC 8-K summary
======================================

Issuer:     Tenaya Therapeutics, Inc. (TNYA)
CIK:        0001858848
Form:       8-K
Filed at:   2026-01-02T23:59:59+00:00
Accession:  0001193125-26-001065
Event type: leadership
Sentiment:  neutral
Materiality: 0.30
Item codes: 5.02
LLM model:  deepseek-v4-flash:cloud@v2

Director David Goeddel resigns from Tenaya board effective Jan 26, 2026
-----------------------------------------------------------------------

- David Goeddel submitted resignation from the Board and all committees on Dec 31, 2025. Effective Jan 26, 2026.
- Resignation due to retirement; no disagreement with Company on operations, policies, or practices.
- Board thanked Dr. Goeddel for his service and contributions.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1858848/000119312526001065/0001193125-26-001065-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1858848/000119312526001065/tnya-20251231.htm
  HTML page:      https://secwatch.observer/filing/0001193125-26-001065

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer